Find out about the ESC Working Groups sessions of interest at ESC Congress 2024
Working Group on Adult Congenital Heart Disease
- Personalised care for atrial septal defect - Joint session with the International Society for Adult Congenital Heart Disease (ISACHD)
- Personalising care in congenital heart disease: a lifecycle perspective
- Personalising cardiovascular care in congenital heart disease - Joint session with the Association for European Paediatric and Congenital Cardiology (AEPC)
- Structural intervention meets adult congenital heart disease
- Guidelines in Practice: a challenging case of endocarditis
- The EHJ’s year in adult congenital heart disease, cardio-oncology, and valvular heart disease - Joint session with the European Heart Journal (EHJ)
- 2024 ESC Guidelines overview
- Novel antithrombotic therapies in cardiovascular disease: what’s on the horizon?
- Guidelines in Practice: 2024 ESC Guidelines for the Management of Elevated Blood Pressure and Hypertension
- Invasive treatment of peripheral arterial disease: these boots are made for walking
- From evolution to disruption: it is all about understanding the natural course of aortic disease
- 2024 ESC Guidelines for the Management of Peripheral Arterial and Aortic Diseases
Working Group on Atherosclerosis and Vascular Biology
Working Group on Cardiac Cellular Electrophysiology
Working Group on Cardiovascular Pharmacotherapy
- When the diet does not work: pharmacological options for obesity
- Personalised dual antiplatelet therapy (DAPT) after acute coronary syndromes: difficult decisions
- Guidelines in Practice: cardio-renal protection in patients with diabetes
- Precision pathways to diabetes management in individuals with cardiovascular disease
- Fixing the obesity crisis
Working Group on Cardiovascular Regenerative and Reparative Medicine
- Novel approaches in cardiac regeneration
- RNA as target and therapeutic tool in cardiovascular diseases
- Gene editing and gene therapies to cure cardiovascular diseases
- Advancements in cardiovascular medicine: from molecular insights to clinical strategies in heart disease management
- RNA-based and epigenetic mechanisms
Working Group on Cardiovascular Surgery
- 2024 ESC Guidelines overview
- Innovations and future frontiers in aortic, mitral, and tricuspid valve therapies
- Hot topics in percutaneous mitral and tricuspid valve interventions
- Heart failure with secondary mitral and tricuspid regurgitation
- From evolution to disruption: it is all about understanding the natural course of aortic disease
Working Group on Cellular Biology of the Heart
- Studies of new biomarkers in heart failure
- Comprehensive diagnosis and treatment of coronary microvascular dysfunction in patients with chronic coronary syndromes - Joint session with the Japanese Circulation Society (JCS) international young community
- Factors influencing the decision to revascularise in chronic coronary syndromes - Joint session with the Brazilian Society of Cardiology (BSC)
- Matrix and fibrosis: experimental aspects
- Smaller trials, trial updates, and other studies on coronary artery disease and coronary revascularisation
Working Group on e-Cardiology
- Using artificial intelligence to bridge gaps in cardiovascular care
- Telehealth interventions in heart failure management: state of the art
- Deep learning and artificial intelligence to transform cardiovascular health
- ChatGPT, Copilot, and other large language models (LLMs): transforming cardiovascular education, care, and science
- Breakthroughs in artificial intelligence-powered cardiac diagnosis and risk prediction
Working Group on Myocardial Function
- New treatment targets for personalised therapy in genetic cardiomyopathies
- Young Investigator Award Session in Basic and Translational Sciences
- Mechanisms of ageing in cardiovascular disease
- RNA as target and therapeutic tool in cardiovascular diseases
- Gene editing and gene therapies to cure cardiovascular diseases
Working Group on Pulmonary Circulation & Right Ventricular Function
- Shaping the future management of pulmonary hypertension - Joint session with the European Respiratory Society (ERS)
- Pulmonary hypertension: from diagnosis to personalised care
- The floor is yours: bring your questions on current management of acute intermediate high-risk pulmonary embolism
- Pulmonary embolism
- Pulmonary hypertension (2)
Working Group on Thrombosis
- Adjunct pharmacology in PCI: beyond antiplatelet therapy, the next chapter
- Novel antithrombotic therapies in cardiovascular disease: what’s on the horizon?
- Personalising antithrombotic therapy in patients with cancer: what every cardiologist should know
- Personalising antithrombotic strategies in acute and chronic coronary syndromes: when and how to escalate and de-escalate
- Registries, observational, and other studies on coronary disease including intervention and surgery
Our mission: To reduce the burden of cardiovascular disease.